Juan Sierra-Madero Selected Research

Substance-Related Disorders (Drug Abuse)

1/2017

Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Sierra-Madero Research Topics

Disease

11	Acquired Immunodeficiency Syndrome (AIDS) 03/2024 - 01/2002
5	HIV Infections (HIV Infection) 01/2016 - 08/2009
4	Tuberculosis (Tuberculoses) 04/2022 - 01/2015
3	COVID-19 11/2022 - 10/2020
3	Opportunistic Infections (Opportunistic Infection) 09/2022 - 10/2011
3	Infections 01/2022 - 01/2002
2	Inflammation (Inflammations) 11/2022 - 01/2017
1	Lymphadenopathy 12/2023
1	Proctitis 12/2023
1	Mpox (monkeypox) 12/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2023
1	Virus Diseases (Viral Diseases) 11/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2020
1	Diabetes Mellitus 05/2020
1	Coronavirus Infections 05/2020
1	Frailty 06/2018
1	Substance-Related Disorders (Drug Abuse) 01/2017
1	Burns 01/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Obesity 01/2015
1	Hypertension (High Blood Pressure) 01/2015
1	Syphilis 01/2015
1	Hepatitis B 01/2015
1	Viremia 01/2014
1	Neoplasms (Cancer) 05/2010
1	Fatty Liver 01/2003
1	Nausea 01/2003
1	Lactic Acidosis 01/2003
1	Acidosis 01/2003
1	Vomiting 01/2003
1	Abdominal Pain (Pain, Abdominal) 01/2003
1	AIDS-Related Opportunistic Infections 01/2003
1	Cytomegalovirus Retinitis 04/2002
1	Retinitis 04/2002

Drug/Important Bio-Agent (IBA)

2	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2022 - 01/2017
2	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 11/2022 - 10/2020
2	Protease Inhibitors (Protease Inhibitor)IBA 09/2022 - 01/2016
2	efavirenz (Sustiva)FDA Link 01/2018 - 01/2014
2	NucleosidesIBA 01/2018 - 01/2003
2	Reverse Transcriptase InhibitorsIBA 01/2018 - 01/2016
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 12/2023
1	pHrodo redIBA 11/2023
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Ritonavir (Norvir)FDA Link 01/2016
1	AntigensIBA 01/2015
1	Blocking AntibodiesIBA 01/2015
1	CholesterolIBA 01/2015
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2015
1	methylmalonyl- methylalanyl- arginyl- p- nitroaniline (SQ 68)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Lopinavir FDA Link 01/2014
1	Myelin Basic ProteinIBA 10/2011
1	Maraviroc FDA Link 05/2010
1	CytokinesIBA 08/2009
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2003
1	EnzymesIBA 01/2003
1	Stavudine (Zerit)FDA LinkGeneric 01/2003
1	Valganciclovir FDA Link 04/2002
1	Ganciclovir (Cytovene)FDA LinkGeneric 04/2002

Therapy/Procedure

8	Therapeutics 11/2022 - 04/2002
5	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 01/2003
4	Art Therapy 03/2024 - 01/2016
3	Artificial Respiration (Mechanical Ventilation) 11/2022 - 10/2020
1	Mechanical Ventilators (Ventilator) 01/2022
1	Length of Stay 01/2022
1	Renal Dialysis (Hemodialysis) 05/2020
1	Activities of Daily Living (ADL) 06/2018
1	Tattooing 01/2017
1	Condoms (Condom) 01/2017
1	Continuity of Patient Care 01/2016
1	Transplantation 01/2016
1	Surgical Amputation (Amputations) 01/2016
1	Blood Transfusion (Blood Transfusions) 01/2002